Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Unicycive Therapeutics, Inc. – The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor…
